Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Paracetamol intravenous - Bristol-Myers Squibb/Mallinckrodt

Drug Profile

Paracetamol intravenous - Bristol-Myers Squibb/Mallinckrodt

Alternative Names: Acelio; acetaminophen IV; Acetavance; IV APAP; Ofirmev; Perfalgan; TRM-1106

Latest Information Update: 31 Dec 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pharmatop
  • Developer Bristol-Myers Squibb; Mallinckrodt plc; Terumo
  • Class Acetanilides; Aminophenols; Antipyretics; Non-opioid analgesics; Small molecules
  • Mechanism of Action Prostaglandin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Fever; Pain

Most Recent Events

  • 02 Jun 2017 No recent reports on development identified - Registered for Fever and Pain in Canada (IV)
  • 18 Nov 2016 Mallinckrodt Pharmaceuticals completes a Pharmacokinetics trial in United Kingdom
  • 08 Nov 2016 The US FDA approved a Prior Approval Supplement for acetaminophen injection
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top